Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. [electronic resource]
Producer: 20130805Description: 439-55 p. digitalISSN:- 1098-1128
- Amaryllidaceae Alkaloids -- adverse effects
- Animals
- Apoptosis -- drug effects
- Brain Neoplasms -- drug therapy
- Cohort Studies
- Cytotoxins -- pharmacology
- Disease Models, Animal
- Dose-Response Relationship, Drug
- GTP Phosphohydrolases -- drug effects
- Glioblastoma -- drug therapy
- Humans
- In Vitro Techniques
- Melanoma -- drug therapy
- Mice
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Phenanthridines -- adverse effects
- Structure-Activity Relationship
- Transplantation, Heterologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.